Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENTRECTINIB vs EPCORITAMAB-BYSP: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ENTRECTINIB vs EPCORITAMAB-BYSP: Safety Overview

Metric ENTRECTINIB EPCORITAMAB-BYSP
Total FAERS Reports 1,491 978
Deaths Reported 246 341
Death Rate 16.5% 34.9%
Hospitalizations 316 199
Average Patient Age 59.8 yrs 71.6 yrs
% Female Patients 58.1% 41.6%
FDA Approval Date Aug 15, 2019 N/A
Manufacturer Genentech, Inc. N/A
Route ORAL N/A
Marketing Status Prescription Prescription